Correlation Between Tanvex BioPharma and Asia Vital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tanvex BioPharma and Asia Vital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tanvex BioPharma and Asia Vital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tanvex BioPharma and Asia Vital Components, you can compare the effects of market volatilities on Tanvex BioPharma and Asia Vital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tanvex BioPharma with a short position of Asia Vital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tanvex BioPharma and Asia Vital.

Diversification Opportunities for Tanvex BioPharma and Asia Vital

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Tanvex and Asia is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and Asia Vital Components in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Asia Vital Components and Tanvex BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tanvex BioPharma are associated (or correlated) with Asia Vital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Asia Vital Components has no effect on the direction of Tanvex BioPharma i.e., Tanvex BioPharma and Asia Vital go up and down completely randomly.

Pair Corralation between Tanvex BioPharma and Asia Vital

Assuming the 90 days trading horizon Tanvex BioPharma is expected to under-perform the Asia Vital. But the stock apears to be less risky and, when comparing its historical volatility, Tanvex BioPharma is 1.22 times less risky than Asia Vital. The stock trades about -0.01 of its potential returns per unit of risk. The Asia Vital Components is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  11,900  in Asia Vital Components on November 19, 2024 and sell it today you would earn a total of  44,300  from holding Asia Vital Components or generate 372.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tanvex BioPharma  vs.  Asia Vital Components

 Performance 
       Timeline  
Tanvex BioPharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tanvex BioPharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Tanvex BioPharma showed solid returns over the last few months and may actually be approaching a breakup point.
Asia Vital Components 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Asia Vital Components has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Tanvex BioPharma and Asia Vital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tanvex BioPharma and Asia Vital

The main advantage of trading using opposite Tanvex BioPharma and Asia Vital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tanvex BioPharma position performs unexpectedly, Asia Vital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Asia Vital will offset losses from the drop in Asia Vital's long position.
The idea behind Tanvex BioPharma and Asia Vital Components pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency